| Literature DB >> 23407455 |
Tucker R Burch1, Michael J Sadowsky, Timothy M Lapara.
Abstract
Numerous initiatives have been undertaken to circumvent the problem of antibiotic resistance, including the development of new antibiotics, the use of narrow spectrum antibiotics, and the reduction of inappropriate antibiotic use. We propose an alternative but complimentary approach to reduce antibiotic resistant bacteria (ARB) by implementing more stringent technologies for treating municipal wastewater, which is known to contain large quantities of ARB and antibiotic resistance genes (ARGs). In this study, we investigated the ability of conventional aerobic digestion to reduce the quantity of ARGs in untreated wastewater solids. A bench-scale aerobic digester was fed untreated wastewater solids collected from a full-scale municipal wastewater treatment facility. The reactor was operated under semi-continuous flow conditions for more than 200 days at a residence time of approximately 40 days. During this time, the quantities of tet(A), tet(W), and erm(B) decreased by more than 90%. In contrast, intI1 did not decrease, and tet(X) increased in quantity by 5-fold. Following operation in semi-continuous flow mode, the aerobic digester was converted to batch mode to determine the first-order decay coefficients, with half-lives ranging from as short as 2.8 days for tet(W) to as long as 6.3 days for intI1. These results demonstrated that aerobic digestion can be used to reduce the quantity of ARGs in untreated wastewater solids, but that rates can vary substantially depending on the reactor design (i.e., batch vs. continuous-flow) and the specific ARG.Entities:
Keywords: aerobic digestion; antibiotic resistance genes; class 1 integrons; municipal wastewater treatment; qPCR
Year: 2013 PMID: 23407455 PMCID: PMC3569665 DOI: 10.3389/fmicb.2013.00017
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Gene targets, resistance mechanisms, primer sequences, amplicon sizes, and annealing temperatures for real-time PCR assays.
| 16S rRNA gene | NA | F: CCT ACG GGA GGC AGC AG | 202 | 60 | Muyzer et al., |
| R: ATT ACC GCG GCT GCT GG | |||||
| NA | F: GAG AGG AAG GTC CCC CAC | 116 | 60 | Layton et al., | |
| R: CGC TAC TTG GCT GGT TCA G | |||||
| Human-specific | NA | F: ATC ATG AGT TCA CAT GTC CG | 82 | 56 | Bernhard and Field, |
| R: TAC CCC GCC TAC TAT CTA ATG | |||||
| Ribosomal protection | F: GAT ACC GTT TAC GAA ATT GG | 364 | 58 | Chen et al., | |
| R: GAA TCG AGA CTT GAG TGT GC | |||||
| Class 1 integron | F: CCT CCC GCA CGA TGA TC | 280 | 60 | Goldstein et al., | |
| R: TCC ACG CAT CGT CAG GC | |||||
| Enzymatic modification | F: CCG TTG GCC TTC CTG TAA AG | 67 | 60 | Heuer and Smalla, | |
| R: TTG CCG ATC GCG TGA AGT | |||||
| Efflux | F: GCT ACA TCC TGC TTG CCT TC | 210 | 60 | Ng et al., | |
| R: CAT AGA TCG CCG TGA AGA GG | |||||
| Ribosomal protection | F: GAG AGC CTG CTA TAT GCC AGC | 168 | 60 | Aminov et al., | |
| R: GGG CGT ATC CAC AAT GTT AAC | |||||
| Enzymatic modification | F: AGC CTT ACC AAT GGG TGT AAA | 278 | 60 | Ghosh et al., | |
| R: TTC TTA CCT TGG ACA TCC CG |
Values of .
| 16S rRNA gene | 1 | 3 × 10−5 | 0.6 | 0.02 | 0.3 | 0.06 | 0.03 | 7 × 10−4 | 0.8 |
| 1 | 2 × 10−4 | 1 × 10−4 | 2 × 10−5 | 5 × 10−5 | 6 × 10−5 | 6 × 10−4 | 3 × 10−5 | ||
| Human-specific | 1 | 0.4 | 0.4 | 1 | 0.9 | 0.1 | 0.6 | ||
| 1 | 9 × 10−3 | 0.1 | 0.2 | 0.1 | 0.02 | ||||
| 1 | 0.01 | 5 × 10−3 | 2 × 10−4 | 0.3 | |||||
| 1 | 0.6 | 4 × 10−3 | 0.02 | ||||||
| 1 | 6 × 10−3 | 0.01 | |||||||
| 1 | 6 × 10−4 | ||||||||
| 1 |
Operating variables during operation in semi-continuous flow mode.
| pH | 7.5 ± 0.2 | |
| Temperature (°C) | 17.0 ± 0.3 | |
| Dissolved oxygen (mg/L) | 5.8 ± 1.5 | |
| Hydraulic residence time (days) | 13.5 ± 0.7 | |
| Untreated total solids | 4.6% ± 0.04% | |
| Treated total solids | 3.4% ± 0.3% | |
| Total solids destruction | 26.3% ± 6.0% | |
| Total solids residence time (days) | 33.1 ± 0.4 | |
| Untreated volatile solids | 3.2% ± 0.05% | |
| Treated volatile solids | 1.9% ± 0.1% | |
| Volatile solids destruction | 41.1% ± 4.8% | |
| Volatile solids residence time (days) | 27.7 ± 0.6 | |
| Untreated inert solids | 1.5% ± 0.02% | |
| Treated inert solids | 1.5% ± 0.1% | |
| Inert solids destruction | −5.7% ± 8.4% | |
| Inert solids residence time (days) | 41.7 ± 0.1 |
Figure 1The quantities of 16S rRNA genes and fecal indicator bacteria as measured by 16S rRNA genes of all Values are the arithmetic mean of triplicate samples; error bars represent one standard deviation. The concentrations of human-specific Bacteroides spp. were approximately 5 × 108 gene copies mL−1 in untreated samples, but were below the detection limit (1×108 gene copies mL−1) in treated samples.
Figure 2The quantities of Values are the arithmetic mean of triplicate samples; error bars represent one standard deviation.
Figure 3The quantities of Values are the arithmetic mean of triplicate samples; error bars represent one standard deviation.
Figure 4The quantities of 16S rRNA genes, fecal indicator bacteria as measured by 16S rRNA genes of all Values are the arithmetic mean of triplicate samples; error bars represent one standard deviation.
Summary of first-order degradation kinetic model parameter estimates for the 16S rRNA gene, fecal indicator bacteria as measured by 16S rRNA genes of all .
| 16S rRNA gene | 0.13 ± 0.008 | 5.5 |
| 0.49 ± 0.048 | 1.4 | |
| Human-specific | 0.15 ± 0.047 | 4.6 |
| 0.19 ± 0.025 | 3.6 | |
| 0.11 ± 0.011 | 6.3 | |
| 0.15 ± 0.009 | 4.6 | |
| 0.16 ± 0.011 | 4.4 | |
| 0.25 ± 0.025 | 2.8 | |
| 0.12 ± 0.006 | 5.7 |
All rates were regressed from 10 data points (except human-specific Bacteroides spp., n = 6) and are statistically significant (P < 0.05).
Figure 5The quantities of Values are the arithmetic mean of triplicate samples; error bars represent one standard deviation.